Patients in the US with newly diagnosed GCA face excessive delays to initiating subcutaneous TCZ, as well high out-of-pocket costs.

Using the latest data and perspectives, an international expert panel releases updated recommendations for optimal insulin ...

The risk for ocular problems linked to different formulations of semaglutide appear to vary, according to a new study, which ...

The partnership extends the compatibility of Sequel’s Twiist system to allow people with Type 1 diabetes to pair the device ...